CXCR4-SF1 Bifunctional Adipose-derived Stem Cells Benefit for the Treatment of Leydig Cell Dysfunction-related Diseases
Overview
Molecular Biology
Authors
Affiliations
Stem cell transplantation is a candidate method for the treatment of Leydig cell dysfunction-related diseases. However, there are still many problems that limit its clinical application. Here, we report the establishment of CXCR4-SF1 bifunctional adipose-derived stem cells (CXCR4-SF1-ADSCs) and their reparative effect on Leydig cell dysfunction. CD29 CD44 CD34 CD45 ADSCs were isolated from adipose tissue and purified by fluorescence-activated cell sorting (FACS). Infection with lentiviruses carrying the CXCR4 and SF1 genes was applied to construct CXCR4-SF1-ADSCs. The CXCR4-SF1-ADSCs exhibited enhanced migration and had the ability to differentiate into Leydig-like cells in vitro. Furthermore, the bifunctional ADSCs were injected into BPA-mediated Leydig cell damage model mice via the tail vein. We found that the CXCR4-SF1-ADSCs were capable of homing to the injured testes, differentiating into Leydig-like cells and repairing the deficiency in reproductive function caused by Leydig cell dysfunction. Moreover, we investigated the mechanism underlying SF1-mediated differentiation and testosterone synthesis in Leydig cells, and the B-box and SPRY Domain Containing Protein (BSPRY) gene was proposed to be involved in this process. This study provides insight into the treatment of Leydig cell dysfunction-related diseases.
Microenvironment of spermatogonial stem cells: a key factor in the regulation of spermatogenesis.
Liu W, Du L, Li J, He Y, Tang M Stem Cell Res Ther. 2024; 15(1):294.
PMID: 39256786 PMC: 11389459. DOI: 10.1186/s13287-024-03893-z.
Is It Possible to Treat Infertility with Stem Cells?.
Petric P, Vrtacnik-Bokal E, Stimpfel M Reprod Sci. 2021; 28(6):1733-1745.
PMID: 33834375 DOI: 10.1007/s43032-021-00566-7.
Li X, Xu A, Li K, Zhang J, Li Q, Zhao G J Cell Mol Med. 2020; 24(8):4633-4645.
PMID: 32181567 PMC: 7176872. DOI: 10.1111/jcmm.15128.